Peptides and related molecules that modulate nerve growth factor activity

Details for Australian Patent Application No. 2003275137 (hide)

Owner Amgen Inc.

Inventors Kimmel, Bruce; Min, Hosung; Wild, Kenneth, D. Jr.; Boone, Thomas C.; Sitney, Karen C.

Agent Shelston IP

Pub. Number AU-B-2003275137

PCT Number PCT/US03/29866

PCT Pub. Number WO2004/026329

Priority 10/666,480 18.09.03 US; 60/412,524 19.09.02 US

Filing date 19 September 2003

Wipo publication date 8 April 2004

Acceptance publication date 13 December 2007

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

12 February 2004 Complete Application Filed

  Priority application(s): 10/666,480 18.09.03 US; 60/412,524 19.09.02 US

20 May 2004 Application Open to Public Inspection

  Published as AU-B-2003275137

13 December 2007 Application Accepted

  Published as AU-B-2003275137

10 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003275138-METHODS AND COMPOSITIONS FOR DETECTING TARGETS

2003275136-A MODULAR BIPOLAR-CMOS-DMOS ANALOG INTEGRATED CIRCUIT AND POWER TRANSISTOR TECHNOLOGY